Baylor University Medical Center Transfusion Services in Dallas underwent an inspection by the Food and Drug Administration on April 22 for blood and blood products, according to data posted on the FDA’s website.
The inspection’s final report noted that no corrective actions were required for any of the facility’s operational procedures.
The FDA regularly checks facilities nationwide to verify adherence to FDA laws and regulations enacted to protect public health. Details from these inspections are made available to the public.
According to its website, the FDA is a federal agency with primary responsibility for regulating the manufacturing and distribution of human and animal drugs, biological products, medical equipment and tobacco goods to ensure their safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
